Expanding the use of abiraterone in prostate cancer: Is earlier always better?

Keith T. Schmidt; Ravi A. Madan; William D. Figg

doi:10.1080/15384047.2017.1394555

Expanding the use of abiraterone in prostate cancer: Is earlier always better?

Keith T. Schmidt, Ravi A. Madan, William D. Figg^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	97-100
Number of pages	4
Journal	Cancer Biology and Therapy
Volume	19
Issue number	2
DOIs	https://doi.org/10.1080/15384047.2017.1394555
State	Published - 1 Feb 2018
Externally published	Yes

Access to Document

10.1080/15384047.2017.1394555

Cite this

@article{6fc9272c846b49e194d935d38fb60a7b,

title = "Expanding the use of abiraterone in prostate cancer: Is earlier always better?",

author = "Schmidt, {Keith T.} and Madan, {Ravi A.} and Figg, {William D.}",

note = "Funding Information: CONTACT William D. Figg, Pharm.D. [email protected] Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bldg 10/Room 5A01, Bethesda, MD 20892.",

year = "2018",

month = feb,

day = "1",

doi = "10.1080/15384047.2017.1394555",

language = "English",

volume = "19",

pages = "97--100",

journal = "Cancer Biology and Therapy",

issn = "1538-4047",

number = "2",

}

TY - JOUR

T1 - Expanding the use of abiraterone in prostate cancer

T2 - Is earlier always better?

AU - Schmidt, Keith T.

AU - Madan, Ravi A.

AU - Figg, William D.

N1 - Funding Information: CONTACT William D. Figg, Pharm.D. [email protected] Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bldg 10/Room 5A01, Bethesda, MD 20892.

PY - 2018/2/1

Y1 - 2018/2/1

UR - http://www.scopus.com/inward/record.url?scp=85041130521&partnerID=8YFLogxK

U2 - 10.1080/15384047.2017.1394555

DO - 10.1080/15384047.2017.1394555

M3 - Article

C2 - 29219670

AN - SCOPUS:85041130521

SN - 1538-4047

VL - 19

SP - 97

EP - 100

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

IS - 2

ER -

Expanding the use of abiraterone in prostate cancer: Is earlier always better?

Access to Document

Fingerprint

Cite this